Rotarix, An Oral Rotavirus Vaccine, Approved By The FDA
The FDA (Food and Drug Administration, USA) has approved Rotarix, an oral vaccine for the prevention of rotavirus - an infection in children and infants which causes vomiting and diarrhea (gastroenteritis). The vaccine, which is presented in liquid form, is given in two doses to infants aged 6 and 24 weeks. It protects against gastroenteritis caused by the G1, G3, G4, and G9 strains of rotavirus.
More: continued here
Filed under: Immune System / Vaccines on April 4th, 2008